Priovant Therapeutics, Inc.

This study tests an oral medication called brepocitinib for people with active uveitis (inflammation inside the eye) that is not caused by an infection. The goal is to see if the drug can control the inflammation and prevent vision loss. About 371 adults aged 18-75 with intermedi…

This study tests an oral medication called brepocitinib in 241 adults with dermatomyositis, a rare disease causing muscle weakness and skin rashes. Participants receive either the drug or a placebo for 52 weeks to see if it improves symptoms. The goal is to find a more effective …